Literature DB >> 4421152

Studies on "big" growth hormone from human plasma and pituitary.

D R Wright, A D Goodman, K D Trimble.   

Abstract

Most of the immunoreactive growth hormone (IRGH) in human plasma elutes from Sephadex G-75 as "little" GH (LGH), mol wt 22,000, but 14-39% elutes earlier ("big" GH, BGH). In saline extracts of human pituitary, 11-17% of IRGH eluted as BGH. On gel filtration of pituitary and plasma BGH in 8 M urea, 59-81% ran as LGH, but when the remaining BGH was refiltered in urea, all ran as BGH. Thus there is a "urea-stable" and a "urea-labile" form of BGH. SImilarly, freezing and thawing converted over half of pituitary and plasma BGH to LGH, but when the "freeze-stable" BGH was again frozen, thawed, and refiltered, almost all ran as BGH. Urea-stable BGH was not dissociated by freezing, and most of the freeze-stable BGH was stable in urea, so the two forms are very similar or identical. Since 8 M urea and freezing dissociate peptides linked by noncovalent bonds, probably the BGH that is dissociated by urea and freezing consists of LGH bound noncovalently to another moiety, while in stable BGH the LGH is bound to another molecule by covalent or unusually strong noncovalent linkage. On centrifugation, the sedimentation of urea-stable BGH was consistent with a mol wt about twice that of LGH. Trypsinization of urea-stable BGH converted 36-59% to LGH, suggesting that some BGH may be a "prohormone" of LGH. On retrypsinization of the BGH that was not converted to LGH, only 13-24% converted, suggesting that there may be two forms of urea-stable BGH which vary in their response to trypsin.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4421152      PMCID: PMC301654          DOI: 10.1172/JCI107850

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Human pituitary growth hormone. VI. Modified procedure of isolation and NH2-terminal amino acid sequence.

Authors:  C H LI; W K LIU; J S DIXON
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

2.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

3.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

4.  Radioreceptor assay for growth hormone.

Authors:  T Tsushima; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1973-08       Impact factor: 5.958

5.  Evidence for possible precursors in the synthesis of growth hormone by rat and human fetal anterior pituitary in vitro.

Authors:  L A Frohman; M E Stachura
Journal:  Mt Sinai J Med       Date:  1973 May-Jun

6.  "Big" growth hormone components from human plasma: decreased reactivity demonstrated by radioreceptor assay.

Authors:  P Gorden; M A Lesniak; C M Hendricks; J Roth
Journal:  Science       Date:  1973-11-23       Impact factor: 47.728

7.  Existence of two forms of immunoreactive growth hormone in human plasma.

Authors:  A D Goodman; R Tanenbaum; D Rabinowitz
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

8.  Gel filtration of albumin on sephadex g-200 in urea.

Authors:  H Olesen; P O Pedersen
Journal:  Acta Chem Scand       Date:  1968

9.  Further studies on the nature of immunoreactive gastrin in human plasma.

Authors:  R S Yalow; S A Berson
Journal:  Gastroenterology       Date:  1971-02       Impact factor: 22.682

10.  Radioreceptor assay for prolactin and other lactogenic hormones.

Authors:  R P Shiu; P A Kelly; H G Friesen
Journal:  Science       Date:  1973-06-01       Impact factor: 47.728

View more
  6 in total

1.  Plasma clearance of heterogeneous growth hormone components in the rat: effects of diabetes and starvation.

Authors:  T Jolin; C González
Journal:  J Endocrinol Invest       Date:  1990-03       Impact factor: 4.256

2.  Metabolic clearance and production rates of prolactin in man.

Authors:  D S Cooper; E C Ridgway; B Kliman; R N Kjellberg; F Maloof
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

3.  Unusual heterogeneity of circulating prolactin in an acromegalic.

Authors:  A D Rogol; R C Eastman; T Manolio; S W Rosen
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

4.  Pituitary gigantism in a 31 month old girl: endocrine studies and successful response to hypophysectomy.

Authors:  E A Espiner; T A Carter; G D Abbott; P Wrightson
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

5.  Effect of growth hormone on oral glucose tolerance and circulating metabolic fuels in man.

Authors:  R S Sherwin; G A Schulman; R Hendler; M Walesky; A Belous; W Tamborlane
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

6.  Identification and characterization of specific binding proteins for growth hormone in normal human sera.

Authors:  A C Herington; S Ymer; J Stevenson
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.